The latest evidence for possible HIV-1 curative strategies
Abstract Human immunodeficiency virus type 1 (HIV-1) infection remains a major health issue worldwide. In developed countries, antiretroviral therapy has extended its reach from treatment of people living with HIV-1 to post-exposure prophylaxis, treatment as prevention, and, more recently, preexposu...
Saved in:
Main Authors: | Hanh Thi Pham (Author), Thibault Mesplède (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection
by: Hanh Thi Pham, et al.
Published: (2020) -
Selection of the R263K and H51Y resistance substitutions for DTG causes diminished integration and explains the lack of clinically significant drug resistance to this compound
by: Thibault Mesplède, et al.
Published: (2016) -
Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review
by: Said A. Hassounah, et al.
Published: (2016) -
The R263K resistance substitution decreases levels of integrated HIV DNA over time
by: Thibault Mesplède, et al.
Published: (2016) -
Educational possibilities of content curation: A literature review
by: Diana Juárez Popoca, et al.
Published: (2017)